NA
Natco Pharma Limited
NATCOPHARM.NS · NSE
₹816.50 -0.26% (-₹2.15)
1M -14.33%
Market Cap ₹146.7B
P/E Ratio 12.82x
Div. Yield 0.18%
ROE 13.41%
Bulios Fair Price
₹993.66
21.7% upside
Trenutna cena
₹816.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NATCOPHARM.NS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
81 /100
Cheap P/E 12.82x
EV/EBITDA 10.74x
P/FCF 14.52x
Growth
93 /100
Growing Rev. growth 14.62%
FCF growth 28.87%
Book val. growth 23.68%
Profitability
99 /100
Strong Gross margin 76.14%
Net margin 32.84%
FCF margin 28.99%
Quality
53 /100
Average ROIC 7.92%
ROE 13.41%
Asset turnover 0.31x
Debt
100 /100
Low Debt/Equity 0.08x
Current ratio 3.01x
Net debt/EBITDA -0.65x
Stability
25 /100
Unstable Beta 0.16x
Rev. volatility 28.36%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NATCOPHARM.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajeev Nannapaneni
Employees
5,051
Headquarters
Hyderabad
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report